Close menu




BASF SE NA

Photo credits: pixabay.com

Commented by Armin Schulz on November 16th, 2026 | 05:33 CET

Rheinmetall, NSJ Antimony and BASF – China's antimony deadline hits ammunition, mining and chemicals

  • Rheinmetall
  • NSJ Antimony
  • BASF
  • Defence
  • Defence industry
  • Ammunition
  • Antimony
  • China
  • Dependence
  • Exploration
  • Chemicals
  • Flame retardants

Created and published on behalf of NSJ Antimony Corp.

An ammunition factory can be built faster than a mine. The West is currently learning this lesson with antimony. The unassuming metalloid hardens lead in ammunition and, as an additive, protects plastics against flames. China is the largest producer. On November 27, the suspension of the Chinese export ban on shipments to the US is due to expire. In the case of rare earths, Beijing granted a two-month postponement on November 9; according to reports so far, no such extension has been granted for antimony. If Beijing turns off the tap, ammunition manufacturers and chemical companies will be the first to feel the impact. We are therefore taking a closer look at Rheinmetall, NSJ Antimony and BASF.

Read

Commented by Matthias Schomber on November 10th, 2026 | 05:23 CET

Chemicals, Defence and Green Returns: What the latest moves and news from BASF, TKMS and RE Royalties mean for savvy retail investors!

  • Return
  • renewable energy
  • green energy
  • Defence
  • Frigates
  • India
  • Chemicals
  • Agriculture
  • Ludwigshafen

The stock market is currently experiencing considerable turbulence. Pressure on certain sectors – most recently defence stocks, chip and memory stocks, and companies whose business models are being challenged by AI – has been intense, resulting in losses that can easily reach double-digit percentages. Meanwhile, chemical and defence stocks such as BASF and TKMS are also fluctuating amid geopolitical tensions and ambitious expansion plans, prompting investors to look for alternatives. Ideally, these should offer strong cash flows and genuine underlying value. The latest quarterly figures and strategic decisions at companies such as RE Royalties suggest that a breath of fresh air could be entering investment portfolios. Those who keep their nerve may also discover compelling opportunities beyond the mainstream.

Read

Commented by Fabian Lorenz on November 6th, 2026 | 05:31 CET

BASF Keeps Up the Pressure on Evonik! Novo Nordisk Makes a Comeback! Is Strategic Resources Next?

  • raw materials
  • steel industry
  • chemicals
  • pharma

A 25% share price gain and a year-high for BASF shares. The increase in the purchase price for Evonik cannot dampen investors' buying appetite. While the Ludwigshafen-based company is not letting up on Evonik, it is divesting parts of the group. Strategic Resources shares are a candidate for a comeback. To reduce CO₂ emissions, the steel industry is turning to electric arc furnaces. This threatens to cause shortages of high-quality iron ore pellets. Strategic Resources plans to supply these in the future. The shares have recently fallen sharply and offer an enticing entry point. At Novo Nordisk, the comeback is already under way. After a challenging year with profit warnings and a massive share price slump, there is finally positive news again. For a change, the full-year guidance was raised, not lowered. What do analysts say?

Read

Commented by Nico Popp on October 30th, 2026 | 05:43 CET

Antimony Countdown: BASF Needs New Supplies as Perpetua Resources and NSJ Antimony Develop North American Sources

  • Antimony
  • Chemicals
  • Flame retardancy
  • Armaments

Created and published on behalf of NSJ Antimony

On November 27, 2026, China's suspension of its antimony export ban to the United States is due to expire. Without an extension by Beijing, US buyers risk losing access to this metalloid, which is essential for flame retardants and armaments. This was reported by industry publication Mining Weekly. According to market information provider Fastmarkets, antimony was trading at USD 18,300 to USD 19,000 per tonne in Rotterdam in mid-October. This is well below the all-time high of approximately USD 59,750 reached in summer 2025. However, the West's dependence on Chinese refineries remains unchanged.

Read

Commented by Fabian Lorenz on October 27th, 2026 | 05:43 CET

Almonty Makes History! Will BASF Bid More for Evonik? Is tonies a Buy?

  • raw materials
  • chemicals
  • toys
  • technology

It is an upside-down world at Almonty at present. While its share price has halved in recent months, the tungsten producer is making operational history. For the first time in more than 30 years, a shipment of tungsten from the Sangdong mine in South Korea has been dispatched. Monthly shipments of around 200 tonnes of the critical raw material are expected to follow soon. Analysts forecast a sharp increase in earnings to USD 2.76 per share next year. The share is currently trading below USD 10. BASF, by contrast, may not be a bargain. The company wants to acquire Evonik and could increase its offer. Although analysts view the plan more positively, they remain cautious about the shares. Meanwhile, analysts recommend tonies as a Buy. Expectations for the upcoming results have risen following a 20% rally, but analysts anticipate strong growth.

Read

Commented by Nico Popp on October 20th, 2026 | 10:04 CEST

Time Limit, Not a Free Pass: What the EU’s Pesticide Decision Means for Bayer, BASF and MustGrow Biologics

  • EU pesticide decision
  • Crop protection
  • Biologics

Created and Published on Behalf of MustGrow Biologics Corp.

On September 30, 2026, the Council of the European Union took a position against indefinite authorisations for synthetic plant protection products and set a maximum term of 15 years for initial authorisations and 25 years for renewals. The member states intend indefinite approvals to be reserved in future for substances with a proven low risk. The member states aim to reach a provisional agreement with the European Parliament by the end of 2026. Regular reassessment of active substances will therefore remain in place for the agrochemical industry, while biological alternatives gain in importance. We analyse the development and present three companies.

Read

Commented by Fabian Lorenz on October 7th, 2026 | 08:50 CEST

Takeover Battle Intensifies: BASF, Evonik, Gerresheimer and Phenom Resources

  • Gold
  • Vanadium
  • chemicals
  • Takeover

The takeover battle surrounding BASF and Evonik is intensifying, and politicians are now getting involved as well. The state government is demanding job guarantees, while the leader of the SPD parliamentary group in North Rhine-Westphalia has voiced criticism and called on Minister President Hendrik Wüst to step up his efforts and provide greater clarity. Phenom Resources is a hot stock with takeover potential. The Canadian company is focused on gold and vanadium projects in the US state of Nevada. Its gold and copper assets are set to be spun off—but could a strategic partner make a move instead? Gerresheimer was already in the crosshairs of financial investors back in 2025. Since the failed takeover attempt, however, things have been relatively quiet. The company is currently restructuring and streamlining its business. That could eventually put it back on potential buyers' radar.

Read

Commented by Matthias Schomber on October 6th, 2026 | 07:30 CEST

From Legacy Issues to Growth Opportunities: Why BASF, Bayer and Zefiro Methane Are Worth Watching

  • methane
  • OrphanWells
  • Pharma
  • chemicals

Created and Published on Behalf of Zefiro Methane Corp.

BASF is working its way through a cost-cutting program and continues to attract investors with a strong dividend. In addition, the chemical giant plans to acquire its competitor Evonik. This strategic acquisition is intended to significantly expand its market power during challenging times. Whether it succeeds, however, remains to be seen. Bayer, too, is undergoing a painful restructuring to address its legacy issues and reduce debt, but offers bold investors attractive turnaround potential—provided much of this effort succeeds. The dynamics across the Atlantic are quite different. There, Zefiro Methane is turning the remediation of abandoned oil and gas wells in North America into a profitable growth business, with strong sales and a promising chart pattern.

Read

Commented by Armin Schulz on October 3rd, 2026 | 06:00 CEST

Bayer, MustGrow Biologics, BASF: From Yesterday's Crop Protection to Tomorrow's Biologicals

  • biologicals
  • agritech
  • mustard
  • agrochemical
  • biofertilizer

Created and Published on Behalf of MustGrow Biologics Corp.

Major agricultural companies are reshaping their businesses and increasingly looking to small specialists. On September 2, Bayer presented its goals for the agricultural business through 2029 to investors. The Leverkusen-based company aims to generate more than EUR 3 billion in free operating cash flow by then and to assume a leading global role in biologicals through partnerships. That could work in the favor of small developers like MustGrow Biologics. On September 14, BASF commissioned four banks to prepare for a potential initial public offering (IPO) of its agricultural division, which generated EUR 9.6 billion in revenue in 2025. We therefore take a closer look at Bayer, MustGrow Biologics and BASF.

Read

Commented by Jens Castner on September 30th, 2026 | 07:30 CEST

The Heart of the European Battery: How BASF, IBU-tec and HPQ Silicon Are Revolutionizing the Battery

  • Silicon
  • Batteries
  • FumedSilica

The future of the European automotive industry will not be decided on the assembly line, but in the chemistry lab. Until now, battery cells—the heart of modern electric vehicles—have come almost exclusively from Asia. This dependency is dangerous, and politicians have warned about it for years: Europe urgently needs its own self-contained battery value chain. But to achieve this independence, it is not enough to simply build massive factories ("gigafactories") on greenfield sites. The real key lies in the molecular components: the cathode (the positive terminal) and the anode (the negative terminal). Three companies are demonstrating how this European supply chain can become a reality: DAX giant BASF is focusing on high-end chemicals for the premium range, while the mid-sized company IBU-tec, with its new mega-factory in Bitterfeld-Wolfen, is poised to become the European LFP cathode leader for the mass market. At the other end of the battery spectrum, the Canadian-French technology firm HPQ Silicon is using innovative silicon anodes to ensure future energy storage systems will be dramatically more powerful. This technological pincer movement could free the continent from Asia's stranglehold. Read on to find out what this means for investors.

Read